Form 4: Insmed Inc. Director Clarissa Desjardins Reports Acquisition of Restricted Stock Units

Clarissa Desjardins, a director of Insmed Inc., reported the acquisition of 5,058 Restricted Stock Units (RSUs) on May 15, 2025, bringing her total holdings to 67,007 shares.

Summary

• On May 15, 2025, Clarissa Desjardins, a director at Insmed Inc., acquired 5,058 Restricted Stock Units (RSUs).
• Each RSU represents a contingent right to receive one share of Insmed Inc. common stock.
• The RSUs vest after one year, contingent upon Ms. Desjardins remaining on the Board of Directors and attending at least 75% of board meetings.
• The RSUs were granted for no consideration.
• Following the transaction, Ms. Desjardins beneficially owns 67,007 shares of Insmed Inc. common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of RSUs by a director is generally a good sign, indicating confidence in the company's future. However, it's a routine transaction.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future performance.

Future Outlook

The RSUs vest after one year, contingent upon continued board membership and meeting attendance requirements.

Industry Context

Acquisition of stock or stock units by company directors is a common practice and is usually viewed as a positive sign of confidence in the company's future.

Stakeholder Impact

• The acquisition of RSUs by a director could positively influence shareholder sentiment.

Key Dates

Keywords

Insmed Inc., Clarissa Desjardins, Director, Restricted Stock Units, RSUs, Beneficial Ownership, Form 4, SEC